Sally Temraz

3.1k total citations
97 papers, 2.1k citations indexed

About

Sally Temraz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sally Temraz has authored 97 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Sally Temraz's work include Colorectal Cancer Treatments and Studies (15 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Global Cancer Incidence and Screening (7 papers). Sally Temraz is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Pancreatic and Hepatic Oncology Research (12 papers) and Global Cancer Incidence and Screening (7 papers). Sally Temraz collaborates with scholars based in Lebanon, United States and Jordan. Sally Temraz's co-authors include Ali Shamseddine, Deborah Mukherji, Rihab Nasr, Farah Nassar, Maya Charafeddine, Malek Kreidieh, Arafat Tfayli, Yolla Haibe, Ibrahim Khalifeh and Hiba El Hajj and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Sally Temraz

88 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sally Temraz Lebanon 27 888 776 462 405 258 97 2.1k
Gregory D. Ayers United States 28 792 0.9× 961 1.2× 401 0.9× 317 0.8× 248 1.0× 55 2.7k
Lu Li China 19 619 0.7× 766 1.0× 489 1.1× 257 0.6× 170 0.7× 73 1.8k
Erika Cecchin Italy 27 1.5k 1.7× 1.2k 1.5× 363 0.8× 406 1.0× 218 0.8× 125 2.6k
Cindy L. O’Bryant United States 23 738 0.8× 917 1.2× 220 0.5× 471 1.2× 126 0.5× 68 2.1k
Catherine C. Lerro United States 8 1.3k 1.5× 758 1.0× 474 1.0× 698 1.7× 371 1.4× 18 2.9k
Michalis Liontos Greece 26 889 1.0× 1.5k 1.9× 469 1.0× 359 0.9× 184 0.7× 125 2.7k
Goura Kishor Rath India 25 786 0.9× 600 0.8× 435 0.9× 746 1.8× 404 1.6× 150 2.6k
Khalil Zaman Switzerland 28 991 1.1× 483 0.6× 476 1.0× 379 0.9× 81 0.3× 100 2.0k
Bin Sun China 31 707 0.8× 1.1k 1.4× 729 1.6× 418 1.0× 299 1.2× 94 3.0k
Giannis Mountzios Greece 30 1.6k 1.8× 1.0k 1.3× 507 1.1× 971 2.4× 230 0.9× 124 3.2k

Countries citing papers authored by Sally Temraz

Since Specialization
Citations

This map shows the geographic impact of Sally Temraz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Temraz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Temraz more than expected).

Fields of papers citing papers by Sally Temraz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Temraz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Temraz. The network helps show where Sally Temraz may publish in the future.

Co-authorship network of co-authors of Sally Temraz

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Temraz. A scholar is included among the top collaborators of Sally Temraz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Temraz. Sally Temraz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Temraz, Sally, et al.. (2023). Can plasma vitamin C predict survival in stage IV colorectal cancer patients? Results of a prospective cohort study. Frontiers in Nutrition. 10. 1110405–1110405. 2 indexed citations
3.
Yang, Tsai‐Sheng, Hong‐Hwa Chen, Tae Won Kim, et al.. (2023). Prospective, open‐label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study. Asia-Pacific Journal of Clinical Oncology. 19(6). 672–680.
4.
Temraz, Sally, et al.. (2023). P-88 Epithelial-to-mesenchymal transition: An emerging prognostic tool in resectable pancreatic cancer, a retrospective study. Annals of Oncology. 34. S44–S45. 1 indexed citations
6.
Temraz, Sally, et al.. (2023). The Ketogenic Diet in Colorectal Cancer: A Means to an End. International Journal of Molecular Sciences. 24(4). 3683–3683. 16 indexed citations
7.
Al‐Omari, Amal, Maya Charafeddine, Mohammad Alrawashdeh, et al.. (2021). Waterpipe Smoking among Bladder Cancer Patients: A Cross-Sectional Study of Lebanese and Jordanian Populations. The Journal of Smoking Cessation. 2021. 6615832–6615832. 3 indexed citations
8.
Bouferraa, Youssef, Yolla Haibe, Maya Charafeddine, et al.. (2021). Comparison Between Liver Stiffness Measurement by Fibroscan and Splenic Volume Index as NonInvasive Tools for the Early Detection of Oxaliplatin-induced Hepatotoxicity. Journal of Clinical and Experimental Hepatology. 12(2). 448–453. 3 indexed citations
9.
Temraz, Sally, Deborah Mukherji, Farah Nassar, Nour Moukalled, & Ali Shamseddine. (2021). Treatment sequencing of metastatic colorectal cancer based on primary tumor location. Seminars in Oncology. 48(2). 119–129. 3 indexed citations
10.
Temraz, Sally, Nour Moukalled, Grigoris Gerotziafas, et al.. (2021). Association between Radiotherapy and Risk of Cancer Associated Venous Thromboembolism: A Sub-Analysis of the COMPASS—CAT Study. Cancers. 13(5). 1033–1033. 14 indexed citations
11.
Kreidieh, Firas & Sally Temraz. (2020). SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020078–e2020078. 6 indexed citations
12.
Husseini, Ziad El, Yolla Haibe, Maya Charafeddine, et al.. (2020). Cystectomy vs. bladder preservation after neoadjuvant chemotherapy in muscle-invasive bladder cancer: A tertiary medical center experience. Cancer Treatment and Research Communications. 25. 100222–100222. 3 indexed citations
13.
Tamim, Hani, et al.. (2020). The impact of age on prognosis in patients with gastric cancer: experience in a tertiary care centre. Journal of Gastrointestinal Oncology. 11(6). 1233–1241. 4 indexed citations
14.
Temraz, Sally, Hani Tamim, Aurélie Mailhac, & Alì Taher. (2018). Could sodium imbalances predispose to postoperative venous thromboembolism? An analysis of the NSQIP database. Thrombosis Journal. 16(1). 11–11. 14 indexed citations
15.
Kouzy, Ramez, et al.. (2018). A Case of Typical Hemolytic Uremic Syndrome in an Adult. Cureus. 10(9). e3289–e3289. 1 indexed citations
16.
Temraz, Sally, et al.. (2018). Perceptions of Cancer Status Disclosure in Lebanon. Journal of Cancer Education. 34(5). 874–881. 4 indexed citations
17.
Mukherji, Deborah, Mark N. Jabbour, Sally Temraz, et al.. (2015). Programmed Death-Ligand 1 Expression in Muscle-Invasive Bladder Cancer Cystectomy Specimens and Lymph Node Metastasis: A Reliable Treatment Selection Biomarker?. Clinical Genitourinary Cancer. 14(2). 183–187. 40 indexed citations
18.
Temraz, Sally, Raafat Alameddine, & Ali Shamseddine. (2015). B-type proto-oncogene-mutated tumors of colon cancer. Current Opinion in Oncology. 27(3). 276–281. 1 indexed citations
20.
Mukherji, Deborah, et al.. (2013). Angiogenesis and anti-angiogenic therapy in prostate cancer. Critical Reviews in Oncology/Hematology. 87(2). 122–131. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026